Equities

Anpario PLC

ANP:LSE

Anpario PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)255.00
  • Today's Change0.00 / 0.00%
  • Shares traded10.63k
  • 1 Year change-2.86%
  • Beta1.0174
Data delayed at least 20 minutes, as of Apr 26 2024 16:29 BST.
More ▼

Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Year on year Anpario PLC's revenues fell -6.36% from 33.10m to 31.00m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from 3.30m to 2.53m, a -23.46% decrease.
Gross margin45.03%
Net profit margin8.16%
Operating margin8.14%
Return on assets5.70%
Return on equity6.74%
Return on investment6.37%
More ▼

Cash flow in GBPView more

In 2023, cash reserves at Anpario PLC fell by 1.20m. However, the company earned 8.70m from its operations for a Cash Flow Margin of 28.05%. In addition the company generated 1.21m cash from investing, though they paid out 10.96m more in financing than they received.
Cash flow per share0.2004
Price/Cash flow per share13.76
Book value per share1.68
Tangible book value per share1.15
More ▼

Balance sheet in GBPView more

Anpario PLC has little financial risk as the capital structure does not rely on leverage.
Current ratio5.13
Quick ratio3.78
Total debt/total equity0.0024
Total debt/total capital0.0023
More ▼

Growth rates in GBP

Year on year, growth in dividends per share increased 1.90% while earnings per share excluding extraordinary items fell by -10.90%. The positive trend in dividend payments is noteworthy since only some companies in the Food Processing industry pay a dividend. Additionally when measured on a five year annualized basis, dividend per share growth is above the industry average relative to its peers, while earnings per share growth is in-line with the industry average.
Div yield(5 year avg)2.42%
Div growth rate (5 year)8.25%
Payout ratio (TTM)84.92%
EPS growth(5 years)-6.20
EPS (TTM) vs
TTM 1 year ago		-9.46
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.